首站-论文投稿智能助手
典型文献
Establishment of an optimized CTC detection model consisting of EpCAM,MUC1 and WT1 in epithelial ovarian cancer and its correlation with clinical characteristics
文献摘要:
Objective:Emerging studies have demonstrated the promising clinical value of circulating tumor cells(CTCs)for diagnosis,disease assessment,treatment monitoring and prognosis in epithelial ovarian cancer.However,the clinical application of CTC remains restricted due to diverse detection techniques with variable sensitivity and specificity and a lack of common standards.Methods:We enrolled 160 patients with epithelial ovarian cancer as the experimental group,and 90 patients including 50 patients with benign ovarian tumor and 40 healthy females as the control group.We enriched CTCs with immunomagnetic beads targeting two epithelial cell surface antigens(EpCAM and MUC1),and used multiple reverse transcription-polymerase chain reaction(RT-PCR)detecting three markers(EpCAM,MUC1 and WT1)for quantification.And then we used a binary logistic regression analysis and focused on EpCAM,MUC1 and WT1 to establish an optimized CTC detection model.Results:The sensitivity and specificity of the optimized model is 79.4%and 92.2%,respectively.The specificity of the CTC detection model is significantly higher than CA125(92.2%vs.82.2%,P=0.044),and the detection rate of CTCs was higher than the positive rate of CA125(74.5%vs.58.2%,P=0.069)in early-stage patients(stage Ⅰ and Ⅱ).The detection rate of CTCs was significantly higher in patients with ascitic volume≥500 mL,suboptimal cytoreductive surgery and elevated serum CA125 level after 2 courses of chemotherapy(P<0.05).The detection rate of CTCEpCAM+and CTCMUC1+was significantly higher in chemo-resistant patients(26.3%vs.11.9%;26.4%vs.13.4%,P<0.05).The median progression-free survival time for CTCMUC1+patients trended to be longer than CTCMUC1-patients,and overall survival was shorter in CTCMUC1+patients(P=0.043).Conclusions:Our study presents an optimized detection model for CTCs,which consists of the expression levels of three markers(EpCAM,MUC1 and WT1).In comparison with CA125,our model has high specificity and demonstrates better diagnostic values,especially for early-stage ovarian cancer.Detection of CTCEpCAM+and CTCMUC1+had predictive value for chemotherapy resistance,and the detection of CTCMUC1+suggested poor prognosis.
文献关键词:
作者姓名:
Tongxia Wang;Yan Gao;Xi Wang;Junrui Tian;Yuan Li;Bo Yu;Cuiyu Huang;Hui Li;Huamao Liang;David M.Irwin;Huanran Tan;Hongyan Guo
作者机构:
Department of Obstetrics and Gynecology,Peking University Third Hospital,Beijing 100191,China;Department of Pharmacology,School of Basic Medical Sciences,Peking University Health Science Center,Beijing 100191,China;Department of Laboratory Medicine and Pathobiology,University of Toronto,Toronto M5S1A8,Canada
引用格式:
[1]Tongxia Wang;Yan Gao;Xi Wang;Junrui Tian;Yuan Li;Bo Yu;Cuiyu Huang;Hui Li;Huamao Liang;David M.Irwin;Huanran Tan;Hongyan Guo-.Establishment of an optimized CTC detection model consisting of EpCAM,MUC1 and WT1 in epithelial ovarian cancer and its correlation with clinical characteristics)[J].中国癌症研究(英文版),2022(02):95-108
A类:
immunomagnetic,ascitic,CTCEpCAM+and,CTCMUC1+was,CTCMUC1+patients,CTCMUC1,CTCMUC1+had,CTCMUC1+suggested
B类:
Establishment,optimized,detection,model,consisting,WT1,epithelial,ovarian,cancer,its,correlation,clinical,characteristics,Objective,Emerging,studies,have,demonstrated,promising,circulating,tumor,cells,CTCs,diagnosis,disease,assessment,treatment,monitoring,prognosis,However,application,remains,restricted,due,diverse,techniques,variable,sensitivity,specificity,lack,common,standards,Methods,We,enrolled,experimental,group,including,benign,healthy,females,control,enriched,beads,targeting,two,surface,antigens,multiple,reverse,transcription,polymerase,chain,reaction,detecting,three,markers,quantification,And,then,binary,logistic,regression,analysis,focused,establish,Results,respectively,significantly,higher,than,CA125,positive,early,stage,volume,suboptimal,cytoreductive,surgery,elevated,serum,after,courses,chemotherapy,resistant,median,progression,free,survival,trended,longer,overall,shorter,Conclusions,Our,study,presents,which,consists,expression,levels,In,comparison,has,demonstrates,better,diagnostic,values,especially,Detection,predictive,resistance,poor
AB值:
0.423586
相似文献
Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
Sung Uk Lee;Jinsil Seong;Tae Hyun Kim;Jung Ho Im;Woo Chul Kim;Kyubo Kim;Hae Jin Park;Tae Gyu Kim;Youngkyong Kim;Bae Kwon Jeong;Jin Hee Kim;Byoung Hyuck Kim;Taek-Keun Nam-Center for Proton Therapy and Center for Liver and Pancreatobiliary Cancer,National Cancer Center,Goyang 10408,Korea;Department of Radiation Oncology,Yonsei Cancer Center,Yonsei University College of Medicine,Seoul 03722,Korea;Department of Radiation Oncology,CHA Bundang Medical Center,CHA University School of Medicine,Seongnam 13497,Korea;Department of Radiation Oncology,Inha University Hospital,Inha University School of Medicine,Incheon 22332,Korea;Department of Radiation Oncology,Ewha Womans University Mokdong Hospital,Ewha Womans University College of Medicine,Seoul 07985,Korea;Department of Radiation Oncology,Hanyang University Medical Center,Hanyang University College of Medicine,Seoul 04763,Korea;Department of Radiation Oncology,Samsung Changwon Hospital,Sungkyunkwan University School of Medicine,Changwon 51353,Korea;Department of Radiation Oncology,Kyung Hee University Hospital,Kyung Hee University College of Medicine,Seoul 02447,Korea;Department of Radiation Oncology,Gyeongsang National University Hospital,Gyeongsang National University College of Medicine,Jinju 52727,Korea;0Department of Radiation Oncology,Dongsan Medical Center,Keimyung University School of Medicine,Daegu 41931,Korea;1Department of Radiation Oncology,Seoul Metropolitan Government Seoul National University Boramae Medical Center,Seoul 07061,Korea;2Department of Radiation Oncology,Chonnam National University Hwasun Hospital,Chonnam National University College of Medicine,Hwasun 58128,Korea
Development and evaluation of the screening performance of a low-cost high-risk screening strategy for breast cancer
Yubei Huang;Huan Wang;Zhangyan Lyu;Hongji Dai;Peifang Liu;Ying Zhu;Fengju Song;Kexin Chen-Department of Cancer Epidemiology and Biostatistics,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy of Tianjin,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Cancer Molecular Epidemiology of Tianjin,Key Laboratory of Breast Cancer Prevention and Therapy,Ministry of Education,Tianjin 300060,China;Department of Breast Imaging,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy of Tianjin,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Cancer Molecular Epidemiology of Tianjin,Key Laboratory of Breast Cancer Prevention and Therapy,Ministry of Education,Tianjin 300060,China
Detection and surveillance of circulating tumor cells in osteosarcoma for predicting therapy response and prognosis
Haoran Mu;Dongqing Zuo;Jie Chen;Zhigang Liu;Zhuo Wang;Liu Yang;Qihui Shi;Yingqi Hua-Shanghai Bone Tumor Institute and Department of Orthopedics,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200080,China;Key Laboratory of Systems Biomedicine(Ministry of Education),Shanghai Center for Systems Biomedicine,Shanghai Jiao Tong University,Shanghai 200240,China;Shanghai Key Laboratory of Medical Epigenetics and the International Co-laboratory of Medical Epigenetics and Metabolism(MOST),Institutes of Biomedical Sciences,Fudan University,Shanghai 200032,China;Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer(SMHC)and Institute of Fudan-Minhang Academic Health System,Minhang Hospital,Fudan University,Shanghai 201199,China;Shanghai Engineering Research Center of Biomedical Analysis Reagents,Shanghai 201203,China
Prognostic role of plasma levels of γ-glutamyl transpeptidase in patients with advanced gastric cancer treated with anti-PD-1 immunotherapy
Shaojie Xu;Yiming Feng;Xingyin Li;Zaozao Huang;Hewei Li;Ganxin Wang-First Clinical College,Huazhong University of Science and Technology,Wuhan 430022,China;Department of Radiology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Yangchunhu Community Hospital,Liyuan Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430077,China;Department of Orthopedics,Liyuan Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430077,China;Cancer Center,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China
Existing tests vs. novel non-invasive assays for detection of invasive aspergillosis in patients with respiratory diseases
Xiao Wei;Du Longyi;Cai Linli;Miao Tiwei;Mao Bing;Wen Fuqiang;Gibson Peter Gerard;Gong Deying;Zeng Yan;Kang Mei;Du Xinmiao;Qu Junyan;Wang Yan;Liu Xuemei;Feng Ruizhi;Fu Juanjuan-Respiratory Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China;Divison of Pulmonary Diseases, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan 610093, China;West China School of Medicine, Sichuan University, Chengdu, Sichuan 610041, China;Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China;Priority Research Centre for Healthy Lungs, The University of Newcastle, Newcastle, NSW 2305, Australia;Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, Newcastle, NSW 2305, Australia;Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW 2305, Australia;Laboratory of Anesthesia and Critical Care Medicine, Translational Neuroscience Center, West China Hospital of Sichuan University, Chengdu, Sichuan 610093, China;Department of Pneumology, Pidu District of Traditional Chinese Medicine, The Third Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 611730, China;Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China;Center of Infectious Disease, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China;Research Core Facility, West China Hospital of Sichuan University, Chengdu, Sichuan 610093, China
Dynamic changes of renal cortical blood perfusion before and after percutaneous transluminal renal artery stenting in patients with severe atherosclerotic renal artery stenosis
Ma Na;Li Yan;Wang Siyu;Li Mengpu;Li Yongjun;Ai Hu;Zhu Hui;Wang Yang;Guo Fajin;Ren Junhong-Department of Sonography, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Vascular Surgery, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Cardiology, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Nuclear Medicine, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Medical Research & Biometrics Center, National Center for Cardiovascular Diseases and Fuwai Hospital, CAMS and PUMC, Beijing 100037, China
Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1
Li Mingzhe;Zhou Jiaxin;Zhang Zhengkui;Li Jisong;Wang Feng;Ma Ling;Tian Xiaodong;Mao Zebin;Yang Yinmo-Department of General Surgery, Peking University First Hospital, Beijing 100034, China;Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, China;Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, China;Department of Surgical Oncology, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University), Beijing 100038, China;Department of Medical Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China
Hepatopancreatoduodenectomy for advanced biliary malignancies
Wu Xiangsong;Li Maolan;Wu Wenguang;Wang Xu’an;Li Huaifeng;Bao Runfa;Shu Yijun;Shen Jun;Gu Jun;Wang Xuefeng;Gong Wei;Peng Shuyou;Liu Yingbin-Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai 200092, China;Shanghai Research Center of Biliary Tract Disease, Shanghai 200092, China;Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;State Key Laboratory of Oncogenes and Related Genes, Shanghai 200092, China;Department of General Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejing 310009, China
Serum mitochondrial tsRNA serves as a novel biomarker for hepatocarcinoma diagnosis
Shoubin Zhan;Ping Yang;Shengkai Zhou;Ye Xu;Rui Xu;Gaoli Liang;Chenyu Zhang;Xi Chen;Liuqing Yang;Fangfang Jin;Yanbo Wang-Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy,State Key Laboratory of Pharmaceutical Biotechnology and Department of Physiology,Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology,NJU Advanced Institute of Life Sciences(NAILS),School of Life Sciences,Nanjing University,Nanjing 210023,China;Department of Clinical Laboratory,The Affiliated Drum Tower Hospital of Nanjing University Medical School,Nanjing 210023,China;Department of Infectious Diseases,The First People's Hospital of Lianyungang,The First Affiliated Hospital of Kangda College of Nanjing Medical University,Lianyungang 222000,China;School of Medicine&Holistic Integrative Medicine,Nanjing University of Chinese Medicine,Nanjing 210023,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。